• Exchange: Soc.Bol SIBE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

GRF:SM

35.8150 EUR 0.7050 2.01%

As of 11:35:20 ET on 11/21/2014.

Snapshot for Grifols SA (GRF)

Open: 35.1250 Day's Range: 35.0350 - 35.9000 Volume: 3,266,005
Previous Close: 35.1100 52wk Range: 27.9100 - 42.5300 1-Yr Rtn: +10.67%

Stock Chart for GRF

No chart data available.
  • GRF:SM 35.8150
  • 1D
  • 1M
  • 1Y
35.1100
Interactive GRF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GRF

Current P/E Ratio (ttm) 29.6959
Estimated P/E(12/2014) 20.8469
Relative P/E vs. IBEX 1.3795
Earnings Per Share (EUR) (ttm) 1.2061
Est. EPS (EUR) (12/2014) 1.7180
Est. PEG Ratio 1.2304
Market Cap (M EUR) 11,534.00
Shares Outstanding (M) 213.06
30 Day Average Volume 1,458,080
Price/Book (mrq) 4.8586
Price/Sale (ttm) 3.9177
Dividend Indicated Gross Yield 0.70%
Cash Dividend (EUR) 0.1975
Dividend Ex-Date
5 Year Dividend Growth -1.58%
Next Earnings Announcement 02/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GRF

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for GRF

Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, Enteral nutrition, diagnostic systems, and medical materials.

Victor Grifols RouraChairman/CEORamon Riera RocaExec VP/Pres:Global Commercial
Alfredo Arroyo GuerraVP/CFOCarlos Roura FernandezVP/Pres:Global Industrial
More Company Profile & Key Executives for GRF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil